Back to results
US 10,946,031 B2Granted
PDE4 inhibitor (R)-4-(5-(4-methoxy-3-propoxyphenyl)pyridin-3-yl)-1,2-oxaborolan-2-ol
AssigneePfizer Inc.
InventorsJoseph Walter Strohbach, David Clive Blakemore, Peter Jones, Matthew Alexander Perry
Life of this patent
Estimating the term…
Abstract
The present invention relates to PDE4 inhibitor (R)-4-(5-(4-methoxy-3-propoxyphenyl)pyridin-3-yl)-1,2-oxaborolan-2-ol including the crystalline monohydrate thereof.
Claims10
A compound of the structure
- or a pharmaceutically acceptable salt thereof.
A compound of the structure
A compound of the structure
- wherein the compound is characterized by a powder X-ray diffraction pattern comprising diffraction peaks at angles (2θ) of 11.0° 0 0.2°, 22.9°±0.2°, and 25.1°±0.2°.
Dependencies are inferred from the claim text.